1. "2023"
Formats
  1. Journal Article (2318)
  2. Meeting Abstract (1954)
  3. Review (629)
  4. Editorial (353)
  5. Book Section (144)
  6. Research Letter (101)
  7. Guidelines (97)
  8. Correspondence (91)
  9. Miscellaneous (57)
  10. Conference Paper (50)
  11. Book Whole (10)
Groups
  1. Department of Medicine (2451)
  2. Solid Tumor Oncology Division (1380)
  3. Sloan Kettering Institute Postdocs (1151)
  4. Hematologic Malignancies, Division of (1038)
  5. GSK Faculty (1016)
  6. Surgery (930)

More Groups

People
  1. Saad Usmani (123)
  2. Sergio Giralt (104)
  3. Miguel-Angel Perales (101)
  4. Gilles Salles (97)
  5. Gunjan Shah (85)
  6. Michael Scordo (81)

More People

Years
  1. 2023 (5804)
Publications
  1. Journal of Clinical Oncology (553)
  2. Blood (402)
  3. Annals of Oncology (154)
  4. Annals of Surgical Oncology (120)
  5. International Journal of Radiation Oncology, Biology, Physics (116)
  6. Laboratory Investigation (88)

More Publications

Publishers
  1. Elsevier Inc. (762)
  2. American Society of Clinical Oncology (606)
  3. American Society of Hematology (478)
  4. Springer (375)
  5. Oxford University Press (359)
  6. Nature Publishing Group (339)

More Publishers

Results (5804)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CCR8 expression as a potential diagnostic and therapeutic biomarker in cutaneous T-cell lymphoma
    Meeting Abstract

    Geller, S.; Moy, A.; Hollmann, T. J.; Pulitzer, M.
    European Journal of Cancer (2023)

    Fulltext@MSK | Save
  • Delphi initiative for early-onset colorectal cancer (DIRECt): International management guidelines
    Meeting Abstract

    Cavestro, G. M.; Mannucci, A.; Balaguer, F.; Heather, H.; Kupfer, S.; Repici, A.; Sartore-Bianchi, A.; Seppälä, T. T.; Valentini, V.; Boland, C. R.; more...
    Digestive and Liver Disease (2023)

    Fulltext@MSK | Save
  • RNA regulators of cellular fate
    Meeting Abstract

    Kharas, M.
    Experimental Hematology (2023)

    Fulltext@MSK | Save
  • Intercepting progression to leukemia in a novel RUNX1-FPD mouse model
    Meeting Abstract

    Goto, H.; Todorova, T.; Schwenger, E.; Taylor, S.; Chen, S.; Narayanagari, S. R.; Sun, D.; Bohorquez, O.; Kumari, R.; Sundaravel, S.; more...
    Experimental Hematology (2023)

    Fulltext@MSK | Save
  • A comprehensive and collaborative workflow to establish customized endpoints and biomarkers for immunotherapy trials
    Meeting Abstract

    Vidal, E. H.; Mcavoy, D.; Vallone, A.; Thomsen, M.; Maslak, P.; Harris, A.; Oved, J.; Hosszu, K.; Boelens, J. J.
    Cytotherapy (2023)

    Fulltext@MSK | Save
  • Real world use of the pediatric disease risk index for allogeneic hematopoietic cell transplantation in patients with acute lymphoblastic leukemia: A multicenter study
    Meeting Abstract

    Lucas, A. T.; Nierkens, S.; de Koning, C.; Dandis, R.; Keerthi, D.; Naik, S.; Prockop, S.; Bhoopalan, S.; Boelens, J. J.; Lindemans, C.; more...
    Cytotherapy (2023)

    Fulltext@MSK | Save
  • High-throughput screening of caterpillars as alternative platform for modeling of gut inflammation
    Meeting Abstract

    Windfelder, A. G.; Müller, F. H. H.; Mc Larney, B.; Hentschel, M.; Böhringer, A. C.; von Bredow, C. R.; Leinberger, F. H.; Kampschulte, M.; Maier, L.; von Bredow, Y. M.; more...
    Developmental and Comparative Immunology (2023)

    Fulltext@MSK | Save
  • Idecabtagene vicleucel (ide-cel) versus standard regimens in patients with triple-class-exposed (TCE) relapsed and refractory multiple myeloma (RRMM): KarMMa-3, A phase III randomized controlled trial (RCT)
    Meeting Abstract

    Giralt, S.; Ailawadhi, S.; Arnulf, B.; Patel, K.; Cavo, M.; Nooka, A. K.; Manier, S.; Callander, N.; Costa, L. J.; Vij, R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of elranatamab by age and frailty in patients with relapsed/refractory multiple myeloma (RRMM): Subgroup analysis from MagnetisMM-3
    Meeting Abstract

    Raje, N.; Leleu, X.; Lesokhin, A.; Mohty, M.; Nooka, A. K.; Leip, E.; Conte, U.; Viqueira, A.; Manier, S.
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Progression-free survival of daratumumab vs bortezomib triplet combination with lenalidomide and dexamethasone in transplant ineligible newly diagnosed multiple myeloma patients: TAURUS chart review study
    Meeting Abstract

    Gordan, L.; Tan, C. R.; Vescio, R.; Ye, J. C.; Schinke, C.; Medhekar, R.; Fu, A. Z.; Lafeuille, M. H.; Thompson-Leduc, P.; Khare, V.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save